Real-world use of osimertinib for epidermal growth factor receptor T790M-positive non-small cell lung cancer in Japan

OBJECTIVE: Adverse drug reactions (ADRs) during real-world osimertinib use were investigated in Japan. METHODS: Patients with epidermal growth factor receptor (EGFR) T790M-positive non-small cell lung cancer treated with second-line or later oral osimertinib per the Japanese package insert (80 mg on...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Jpn J Clin Oncol
Main Authors: Ohe, Yuichiro, Kato, Terufumi, Sakai, Fumikazu, Kusumoto, Masahiko, Endo, Masahiro, Saito, Yoshinobu, Baba, Tomohisa, Sata, Masafumi, Yamaguchi, Ou, Sakamoto, Kei, Sugeno, Masatoshi, Tamura, Reiko, Tokimoto, Toshimitsu, Shimizu, Wataru, Gemma, Akihiko
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7401719/
https://ncbi.nlm.nih.gov/pubmed/32548617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyaa067
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados